- Home
- BYSI vs INMB Comparison
BYSI vs INMB Comparison
Compare BYSI & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYSI
- INMB
- Stock Information
- Founded
- BYSI 2010
- INMB 2015
- Country
- BYSI United States
- INMB United States
- Employees
- BYSI N/A
- INMB N/A
- Industry
- BYSI Biotechnology: Pharmaceutical Preparations
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- BYSI Health Care
- INMB Health Care
- Exchange
- BYSI Nasdaq
- INMB Nasdaq
- Market Cap
- BYSI 80.6M
- INMB 68.9M
- IPO Year
- BYSI 2017
- INMB 2019
- Fundamental
- Price
- BYSI $2.02
- INMB $2.53
- Analyst Decision
- BYSI
- INMB Buy
- Analyst Count
- BYSI 0
- INMB 4
- Target Price
- BYSI N/A
- INMB $9.53
- AVG Volume (30 Days)
- BYSI 26.9K
- INMB 2.9M
- Earning Date
- BYSI 08-13-2025
- INMB 08-07-2025
- Dividend Yield
- BYSI N/A
- INMB N/A
- EPS Growth
- BYSI N/A
- INMB N/A
- EPS
- BYSI N/A
- INMB N/A
- Revenue
- BYSI N/A
- INMB $50,000.00
- Revenue This Year
- BYSI N/A
- INMB $212.27
- Revenue Next Year
- BYSI N/A
- INMB $10,184.28
- P/E Ratio
- BYSI N/A
- INMB N/A
- Revenue Growth
- BYSI N/A
- INMB N/A
- 52 Week Low
- BYSI $0.98
- INMB $1.89
- 52 Week High
- BYSI $3.44
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- BYSI 45.52
- INMB 41.61
- Support Level
- BYSI $1.96
- INMB $2.42
- Resistance Level
- BYSI $2.14
- INMB $2.61
- Average True Range (ATR)
- BYSI 0.12
- INMB 0.22
- MACD
- BYSI 0.01
- INMB 0.09
- Stochastic Oscillator
- BYSI 30.30
- INMB 26.67
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.